Abstract 5235: Transcriptome-wide study of tumor samples from Peruvian women identifies dysregulated pathways in luminal tumors typically associated with more aggressive disease
Chenghuiyun Xu(University of California, Davis), Laura Fejerman(University of California, San Francisco), Luís Más(Instituto Nacional de Enfermedades Neoplásicas), Tatiana Vidaurre(The University of Texas MD Anderson Cancer Center), Carlos A. Castañeda(Instituto Nacional de Enfermedades Neoplásicas), Silvia P. Neciosup(Instituto Nacional de Enfermedades Neoplásicas), Jule F Vasquez(Instituto Nacional de Enfermedades Neoplásicas), Xiaosong Huang(University of California, Davis), Jovanny Zabaleta(Stanley Foundation), Valentina A. Zavala-Cordero(University of California, Davis), Henry Gómez(National Cancer Center), Ruddy Liendo-Picoaga(Instituto Nacional de Enfermedades Neoplásicas), David M. Rocke(University of California, Davis), Marco Gálvez-Niño(Instituto Nacional de Enfermedades Neoplásicas), Sandro Casavilca‐Zambrano(Institute for Anthropological Research), Hugo Fuentes(Instituto Nacional de Enfermedades Neoplásicas), Julio E. Abugattas(City of Hope), Kátia Roque(Instituto Nacional de Enfermedades Neoplásicas), Zaida Morante, Guillermo Valencia(Instituto Nacional de Enfermedades Neoplásicas), Mónica Calderón(Instituto Nacional de Enfermedades Neoplásicas), Jeannie Navarro-Vásquez(Instituto Nacional de Enfermedades Neoplásicas), José M. Cotrina(Instituto Nacional de Enfermedades Neoplásicas)
Cited by 0
Related Papers
5th ESO-ESMO international consensus guidelines for advanced breast cancer (ABC 5)
|Annals of Oncology|2020|1.4k
Adjuvant Exemestane with Ovarian Suppression in Premenopausal Breast Cancer
|New England Journal of Medicine|2014|751
Tailoring Adjuvant Endocrine Therapy for Premenopausal Breast Cancer
|New England Journal of Medicine|2018|684
High-dose cytarabine plus high-dose methotrexate versus high-dose methotrexate alone in patients with primary CNS lymphoma: a randomised phase 2 trial
|The Lancet|2009|665
Ixabepilone Plus Capecitabine for Metastatic Breast Cancer Progressing After Anthracycline and Taxane Treatment
|Journal of Clinical Oncology|2007|483